In this video, Dr. El-Khoueiry discusses results from a phase I/II study that suggest the PD-1 inhibitor nivolumab is safe and effective in advanced hepatocellular carcinoma.
Anthony B. El-Khoueiry, MD
Advertisement
Articles by Anthony B. El-Khoueiry, MD
Advertisement
Latest Updated Articles
PD-1 Inhibitor Yields Responses in Hepatocellular CarcinomaPublished: June 8th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Lenvatinib/Everolimus Beats Cabozantinib in Phase 2 RCC Study
2
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
3
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
4
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
5
